These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. SOHO State of the Art Update and Next Questions: Current and Emerging Therapies for Systemic Mastocytosis. Chifotides HT; Bose P Clin Lymphoma Myeloma Leuk; 2024 Jun; ():. PubMed ID: 39168723 [TBL] [Abstract][Full Text] [Related]
5. Systemic mastocytosis in adults: 2021 Update on diagnosis, risk stratification and management. Pardanani A Am J Hematol; 2021 Apr; 96(4):508-525. PubMed ID: 33524167 [TBL] [Abstract][Full Text] [Related]
6. New developments in diagnosis, prognostication, and treatment of advanced systemic mastocytosis. Reiter A; George TI; Gotlib J Blood; 2020 Apr; 135(16):1365-1376. PubMed ID: 32106312 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of avapritinib in previously treated patients with advanced systemic mastocytosis. Reiter A; Schwaab J; DeAngelo DJ; Gotlib J; Deininger MW; Pettit KM; Alvarez-Twose I; Vannucchi AM; Panse J; Platzbecker U; Hermine O; Dybedal I; Lin HM; Rylova SN; Ehlert K; Dimitrijević S; Radia DH Blood Adv; 2022 Nov; 6(21):5750-5762. PubMed ID: 35640224 [TBL] [Abstract][Full Text] [Related]
8. Advanced systemic mastocytosis-Revised classification, new drugs and how we treat. Pardanani A; Reichard K; Tefferi A Br J Haematol; 2024 Feb; 204(2):402-414. PubMed ID: 38054381 [TBL] [Abstract][Full Text] [Related]